Sun Pharmaceuticals: Decoding Doxil opportunity ::Kotak Securities (PDF link)

Please Share::  India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��

http://www.kotaksecurities.com/pdf/indiadaily/indiadaily02032012.pdf


Company
Sun Pharmaceuticals: Decoding Doxil opportunity
` Sun to supply liposomal doxorubicin to bridge shortage of Doxil
` Doxorubicin has gone generic but there is no generic for Doxil (liposomal
doxorubicin) yet
` Sizing up the opportunity for Sun remains difficult at this moment
` We await Sun's FY2013E sales growth guidance